214 related articles for article (PubMed ID: 10490895)
1. Jun N-terminal kinase in rheumatoid arthritis.
Han Z; Boyle DL; Aupperle KR; Bennett B; Manning AM; Firestein GS
J Pharmacol Exp Ther; 1999 Oct; 291(1):124-30. PubMed ID: 10490895
[TBL] [Abstract][Full Text] [Related]
2. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.
Sundarrajan M; Boyle DL; Chabaud-Riou M; Hammaker D; Firestein GS
Arthritis Rheum; 2003 Sep; 48(9):2450-60. PubMed ID: 13130464
[TBL] [Abstract][Full Text] [Related]
3. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
4. A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.
Cha HS; Boyle DL; Inoue T; Schoot R; Tak PP; Pine P; Firestein GS
J Pharmacol Exp Ther; 2006 May; 317(2):571-8. PubMed ID: 16452391
[TBL] [Abstract][Full Text] [Related]
5. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.
Han Z; Boyle DL; Chang L; Bennett B; Karin M; Yang L; Manning AM; Firestein GS
J Clin Invest; 2001 Jul; 108(1):73-81. PubMed ID: 11435459
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38.
Westermarck J; Holmström T; Ahonen M; Eriksson JE; Kähäri VM
Matrix Biol; 1998 Dec; 17(8-9):547-57. PubMed ID: 9923649
[TBL] [Abstract][Full Text] [Related]
7. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
[TBL] [Abstract][Full Text] [Related]
8. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.
Chabaud-Riou M; Firestein GS
Am J Pathol; 2004 Jan; 164(1):177-84. PubMed ID: 14695331
[TBL] [Abstract][Full Text] [Related]
10. Regulation of JNK by MKK-7 in fibroblast-like synoviocytes.
Inoue T; Hammaker D; Boyle DL; Firestein GS
Arthritis Rheum; 2006 Jul; 54(7):2127-35. PubMed ID: 16802349
[TBL] [Abstract][Full Text] [Related]
11. Role of protein tyrosine kinase in IL-1 beta induced activation of mitogen-activated protein kinase in fibroblast-like synoviocytes of rheumatoid arthritis.
Lu H; Sun T; Yao L; Zhang Y
Chin Med J (Engl); 2000 Oct; 113(10):872-6. PubMed ID: 11775830
[TBL] [Abstract][Full Text] [Related]
12. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
[TBL] [Abstract][Full Text] [Related]
14. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
Toh ML; Yang Y; Leech M; Santos L; Morand EF
Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
[TBL] [Abstract][Full Text] [Related]
15. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways.
Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F
Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts.
Mun SH; Kim JW; Nah SS; Ko NY; Lee JH; Kim JD; Kim DK; Kim HS; Choi JD; Kim SH; Lee CK; Park SH; Kim BK; Kim HS; Kim YM; Choi WS
Arthritis Rheum; 2009 Mar; 60(3):678-85. PubMed ID: 19248119
[TBL] [Abstract][Full Text] [Related]
19. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis.
Han Z; Chang L; Yamanishi Y; Karin M; Firestein GS
Arthritis Rheum; 2002 Mar; 46(3):818-23. PubMed ID: 11920420
[TBL] [Abstract][Full Text] [Related]
20. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
